Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Final lecture in Darwin series presented at the UFS
2010-02-23

At the lecture were, from the left: Prof. Terence McCarthy, Prof. Jo van As, Chairperson of the Darwin 200 Committee and Head of the Department of Zoology and Entomology at the UFS, Prof. Bruce Rubidge, Elsabe Brits, journalist at Die Burger and Esther van der Westhuizen, presenter on Groen.
Photo: Leonie Bolleurs


The University of the Free State (UFS), in collaboration with the Central University of Technology, Free State (CUT) and The National Museum in Bloemfontein recently hosted the final lecture on the Charles Darwin lecture series entitled “The story of life and survival”.

The lecture was presented by Prof. Bruce Rubidge, the Director of the Bernard Price Institute for Paleontological Research at Wits University and Prof. Terence McCarthy, a Professor of Mineral Geochemistry at Wits and Head of the Department of Geology. Proff. Rubidge and McCarthy are co-authors of the book The Story of Life on Earth.

Their lecture with the topic “Trends in evolution and their bearing on the future of humankind” dealt with the future of evolution. According to Prof. Rubidge, ninety-nine percent of the species that have ever lived are extinct. “We are living in a time of mass extinction. Fifty thousand species become extinct annually,” he said.

Prof. McCarthy discussed many factors that can result in mankind’s extinction today. The impact of climate change, big volcanic eruptions, a comet or asteroid hitting earth, tsunamis and the collapsing of sea islands are some of the factors Prof. McCarthy believes could cause great catastrophe’s on earth.

“We live on the brink of this all the time,” he said.

Prof. McCarthy also believes that we can avoid these catastrophes. By allowing only one child per family we can shrink the global population with 30% per generation. This is doable in a short time span,” he said.

Other ideas he had on saving mankind from getting extinct is to create extensive ecological reserves on land but especially in the ocean, to decentralise everything, to change to renewable energy, to recycle resources and to be vigilant in doing this.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept